Medical Devices
Instruments, implants and equipment used to diagnose, monitor and treat disease across every clinical specialty.
Market Research. Real Impact.
Independent forecasts and analyst coverage across the global healthcare ecosystem — sized bottom-up, refreshed quarterly and built to survive an investment committee.
Market Reports
Refreshed on a rolling 90-day cycle.
Healthcare Segments
From imaging to regenerative medicine.
Markets / Countries
Clinical, regulatory and commercial coverage.
Years of Research
Comparable series back to 2011.
Healthcare Ecosystem
Explore the core segments shaping healthcare, life sciences, medical technology and connected health services — researched as one system rather than as separate markets.
Instruments, implants and equipment used to diagnose, monitor and treat disease across every clinical specialty.
Human medicines by therapeutic class, approval pathway and delivery format, prescription through over-the-counter.
Biologically manufactured therapeutics with the bioprocessing and genomics platforms that produce and characterise them.
Care delivered as a service: providers, clinical research organisations and pharmacy operations.
Clinical software and data systems: records, imaging, prescribing, interoperability and regulated diagnostic software.
Veterinary medicines, biologics, devices, feed and clinical services for companion animals and livestock.
Method
Every study is built the same way, so numbers stay comparable across markets and across years.
Bottom-up models with visible assumptions, procedure volumes and unit economics — not black-box totals.
Every dataset ships with a written read: what moved, who gained share and what to watch next quarter.
Share ladders, launch tracking and clearance timelines for the vendors in your category.
Latest Intelligence
Stay current with the latest analysis from across the healthcare ecosystem.
BlogHealthcare IT
AI-enabled digital health software and Software as a Medical Device (SaMD) are moving from pilots to operational deployments—but success depends less on model novelty and more on evidence, workflow fit, and governance across the healthcare IT stack.
BlogHealthcare IT
AI-enabled digital health and Software as a Medical Device (SaMD) are moving from pilot programs to operational deployments—driven by clinical capacity constraints, expanding data availability, and maturing regulatory expectations. This article maps the technology landscape, adoption drivers, constraints, and go-to-market implications for healthcare and medtech stakeholders.
Featured Research
Discover the latest research published across the healthcare ecosystem.
USD 490 Million
USD 2.11 Billion
USD 810 Million
Latest Updates
Newsletters and company announcements from the MedInsight research team.
Press ReleaseMedical Devices
MedInsight (ResearchX) has launched expanded research coverage focused on cardiovascular and endovascular medical devices, assessing technology trends, clinical adoption dynamics, and procurement and regulatory considerations shaping the category.
Press ReleaseHealthcare IT
MedInsight (ResearchX) has published expanded research coverage examining AI-enabled digital health software and Software as a Medical Device (SaMD), with a focus on clinical adoption drivers, regulatory considerations, and commercialization dynamics across care settings.
The Platform
Analysts, product teams and investors work from the same models — with every assumption visible and every revision dated.
Model by device class, installed base and replacement cadence.
Reimbursement codes mapped to realised average selling prices.
Nine regions and 40 country models with local regulatory notes.
Trials, clearances and launches linked to the markets they move.
Installed base forecast+9.4% CAGR
Get custom research on any market in the healthcare ecosystem, tailored to your business question. An analyst will scope the work, agree the method with you and deliver a model you can interrogate.
Market intelligence, emerging trends and research updates delivered to your inbox.